{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T03:50:21Z","timestamp":1790394621629,"version":"4.1.0"},"reference-count":52,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2018,6,29]],"date-time":"2018-06-29T00:00:00Z","timestamp":1530230400000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100004897","name":"American Cancer Society","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004897","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001253","name":"Multiple Myeloma Research Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001253","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000738","name":"U.S. Department of Veterans Affairs","doi-asserted-by":"publisher","award":["VA 2 I01 CX000623"],"award-info":[{"award-number":["VA 2 I01 CX000623"]}],"id":[{"id":"10.13039\/100000738","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000069","name":"National Institute of Arthritis and Musculoskeletal and Skin Diseases","doi-asserted-by":"publisher","award":["R01 AR059679"],"award-info":[{"award-number":["R01 AR059679"]}],"id":[{"id":"10.13039\/100000069","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004897","name":"Pennsylvania Department of Health","doi-asserted-by":"publisher","award":["4100057687"],"award-info":[{"award-number":["4100057687"]}],"id":[{"id":"10.13039\/100004897","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["P30 DA035778"],"award-info":[{"award-number":["P30 DA035778"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"DOI":"10.3389\/fendo.2018.00344","type":"journal-article","created":{"date-parts":[[2018,6,29]],"date-time":"2018-06-29T04:18:37Z","timestamp":1530245917000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":29,"title":["XRK3F2 Inhibition of p62-ZZ Domain Signaling Rescues Myeloma-Induced GFI1-Driven Epigenetic Repression of the Runx2 Gene in Pre-osteoblasts to Overcome Differentiation Suppression"],"prefix":"10.3389","volume":"9","author":[{"given":"Juraj","family":"Adamik","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca","family":"Silbermann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"Marino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Quanhong","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Judith L.","family":"Anderson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiang-Qun","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G. David","family":"Roodman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deborah L.","family":"Galson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2018,6,29]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1038\/leu.2013.258","article-title":"Relationship between initial clinical presentation and the molecular cytogenetic classification of myeloma","volume":"28","author":"Greenberg","year":"2014","journal-title":"Leukemia"},{"key":"B2","doi-asserted-by":"publisher","first-page":"9","DOI":"10.3322\/caac.21208","article-title":"Cancer statistics, 2014","volume":"64","author":"Siegel","year":"2014","journal-title":"CA"},{"key":"B3","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1038\/leu.2008.336","article-title":"Pathogenesis of myeloma bone disease","volume":"32","author":"Roodman","year":"2004","journal-title":"Blood Cells Mol Dis."},{"key":"B4","doi-asserted-by":"publisher","first-page":"1860","DOI":"10.1002\/cncr.22991","article-title":"Pathologic fractures correlate with reduced survival in patients with malignant bone disease","volume":"110","author":"Saad","year":"2007","journal-title":"Cancer"},{"key":"B5","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1586\/17474086.2013.874943","article-title":"Management of bone disease in multiple myeloma","volume":"7","author":"Terpos","year":"2014","journal-title":"Expert Rev Hematol."},{"key":"B6","doi-asserted-by":"publisher","first-page":"2016","DOI":"10.1158\/0008-5472.CAN-03-1131","article-title":"Cancer and the microenvironment: myeloma-osteoclast interactions as a model","volume":"64","author":"Yaccoby","year":"2004","journal-title":"Cancer Res."},{"key":"B7","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1111\/j.1600-0609.1992.tb00046.x","article-title":"Abnormal bone remodelling in patients with myelomatosis and normal biochemical indices of bone resorption","volume":"49","author":"Taube","year":"1992","journal-title":"Eur J Haematol."},{"key":"B8","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1097\/00003086-198309000-00041","article-title":"Fracture healing in metastatic bone disease","volume":"178","author":"Gainor","year":"1983","journal-title":"Clin Orthopaed Related Res."},{"key":"B9","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1007\/978-1-4419-1050-9_5","article-title":"Regulation of osteoblast differentiation by Runx2","volume":"658","author":"Komori","year":"2010","journal-title":"Adv Exp Med Biol."},{"key":"B10","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1038\/leu.2011.196","article-title":"Risk of progression and survival in multiple myeloma relapsing after therapy with IMiDs and bortezomib: a multicenter international myeloma working group study","volume":"26","author":"Kumar","year":"2012","journal-title":"Leukemia"},{"key":"B11","doi-asserted-by":"publisher","first-page":"172458","DOI":"10.1155\/2015\/172458","article-title":"Mechanism of action of bortezomib and the new proteasome inhibitors on myeloma cells and the bone microenvironment: impact on myeloma-induced alterations of bone remodeling","volume":"2015","author":"Accardi","year":"2015","journal-title":"BioMed Res Int."},{"key":"B12","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1158\/1078-0432.CCR-11-2212","article-title":"Multiple myeloma mesenchymal stem cells: characterization, origin, and tumor-promoting effects","volume":"18","author":"Reagan","year":"2012","journal-title":"Clin Cancer Res."},{"key":"B13","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1016\/j.bone.2007.12.006","article-title":"Dkk1-induced inhibition of Wnt signaling in osteoblast differentiation is an underlying mechanism of bone loss in multiple myeloma","volume":"42","author":"Qiang","year":"2008","journal-title":"Bone"},{"key":"B14","doi-asserted-by":"publisher","first-page":"e27","DOI":"10.1038\/bcj.2011.22","article-title":"Myeloma cells suppress osteoblasts through sclerostin secretion","volume":"1","author":"Colucci","year":"2011","journal-title":"Blood Cancer J."},{"key":"B15","doi-asserted-by":"publisher","first-page":"3992","DOI":"10.1182\/blood-2006-05-026112","article-title":"Multiple myeloma bone disease: pathophysiology of osteoblast inhibition","volume":"108","author":"Giuliani","year":"2006","journal-title":"Blood"},{"key":"B16","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1038\/bonekey.2012.135","article-title":"Mechanisms of multiple myeloma bone disease","volume":"1","author":"Galson","year":"2012","journal-title":"BoneKEy Rep."},{"key":"B17","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1186\/s12935-014-0132-6","article-title":"Osteoblast inhibition by chemokine cytokine ligand3 in myeloma-induced bone disease","volume":"14","author":"Fu","year":"2014","journal-title":"Cancer Cell Int."},{"key":"B18","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1172\/JCI24281","article-title":"Paget disease of bone","volume":"115","author":"Roodman","year":"2005","journal-title":"J Clin Invest."},{"key":"B19","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.tibs.2006.12.002","article-title":"Signal integration and diversification through the p62 scaffold protein","volume":"32","author":"Moscat","year":"2007","journal-title":"Trends Biochem Sci."},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1186\/1750-2187-7-1","article-title":"The adaptor protein p62\/SQSTM1 in osteoclast signaling pathways","volume":"7","author":"McManus","year":"2012","journal-title":"J Mol Signal."},{"key":"B21","doi-asserted-by":"publisher","first-page":"1161","DOI":"10.1080\/15548627.2015.1052928","article-title":"A plastic SQSTM1\/p62-dependent autophagic reserve maintains proteostasis and determines proteasome inhibitor susceptibility in multiple myeloma cells","volume":"11","author":"Milan","year":"2015","journal-title":"Autophagy"},{"key":"B22","doi-asserted-by":"publisher","first-page":"14814","DOI":"10.18632\/oncotarget.4530","article-title":"KLF4-SQSTM1\/p62-associated prosurvival autophagy contributes to carfilzomib resistance in multiple myeloma models","volume":"6","author":"Riz","year":"2015","journal-title":"Oncotarget"},{"key":"B23","doi-asserted-by":"publisher","first-page":"4894","DOI":"10.1182\/blood-2008-08-173948","article-title":"Increased signaling through p62 in the marrow microenvironment increases myeloma cell growth and osteoclast formation","volume":"113","author":"Hiruma","year":"2009","journal-title":"Blood"},{"key":"B24","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.1182\/blood.V96.5.1953","article-title":"Cell-cell contact between marrow stromal cells and myeloma cells via VCAM-1 and alpha(4)beta(1)-integrin enhances production of osteoclast-stimulating activity","volume":"96","author":"Michigami","year":"2000","journal-title":"Blood"},{"key":"B25","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.leukres.2015.10.004","article-title":"Small interfering RNA silencing of interleukin-6 in mesenchymal stromal cells inhibits multiple myeloma cell growth","volume":"40","author":"Teoh","year":"2016","journal-title":"Leukemia Res."},{"key":"B26","doi-asserted-by":"crossref","first-page":"2412","DOI":"10.1101\/gad.13.18.2412","article-title":"RANK is essential for osteoclast and lymph node development","volume":"13","author":"Dougall","year":"1999","journal-title":"Genes Dev."},{"key":"B27","doi-asserted-by":"publisher","first-page":"1566","DOI":"10.1073\/pnas.97.4.1566","article-title":"RANK is the intrinsic hematopoietic cell surface receptor that controls osteoclastogenesis and regulation of bone mass and calcium metabolism","volume":"97","author":"Li","year":"2000","journal-title":"Proc Natl Acad Sci U S A."},{"key":"B28","first-page":"128","article-title":"The ZZ domain of sequestosome-1\/p62 plays an important role in stromal cell support of myeloma cell growth and osteoclast formation","volume":"116","author":"Teramachi","year":"2010","journal-title":"ASH Annu Meet Abstr."},{"key":"B29","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1038\/leu.2015.229","article-title":"Blocking the ZZ domain of sequestosome1\/p62 suppresses myeloma growth and osteoclast formation in vitro and induces dramatic bone formation in myeloma-bearing bones in vivo.","volume":"30","author":"Teramachi","year":"2016","journal-title":"Leukemia"},{"key":"B30","doi-asserted-by":"publisher","first-page":"6871","DOI":"10.1182\/blood-2011-04-346775","article-title":"Gfi1 expressed in bone marrow stromal cells is a novel osteoblast suppressor in patients with multiple myeloma bone disease","volume":"118","author":"D'Souza","year":"2011","journal-title":"Blood"},{"key":"B31","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1158\/1541-7786.MCR-16-0242-T","article-title":"EZH2 or HDAC1 inhibition reverses multiple myeloma-induced epigenetic suppression of osteoblast differentiation","volume":"15","author":"Adamik","year":"2017","journal-title":"Mol Cancer Res."},{"key":"B32","doi-asserted-by":"publisher","first-page":"1270","DOI":"10.1016\/j.cellsig.2016.06.004","article-title":"AMPK promotes osteogenesis and inhibits adipogenesis through AMPK-Gfi1-OPN axis","volume":"28","author":"Wang","year":"2016","journal-title":"Cell Signal"},{"key":"B33","doi-asserted-by":"publisher","first-page":"1834","DOI":"10.1038\/leu.2010.195","article-title":"Gfi1 and Gfi1b: key regulators of hematopoiesis","volume":"24","author":"van der Meer","year":"2010","journal-title":"Leukemia"},{"key":"B34","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/j.cytogfr.2012.09.002","article-title":"Snail\/Gfi-1 (SNAG) family zinc finger proteins in transcription regulation, chromatin dynamics, cell signaling, development, and disease","volume":"24","author":"Chiang","year":"2013","journal-title":"Cytokine Growth Factor Rev."},{"key":"B35","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1182\/blood.V122.21.753.753","article-title":"Increase of Gfi1 acetylation by HDAC inhibitors blocks Gfi1-mediated Runx2 repression in osteoblast precursors in multiple myeloma bone disease","volume":"122","author":"Wang","year":"2013","journal-title":"Blood"},{"key":"B36","doi-asserted-by":"publisher","first-page":"3853","DOI":"10.1128\/MCB.00032-10","article-title":"Gfi1 expression is controlled by five distinct regulatory regions spread over 100 kilobases, with Scl\/Tal1, Gata2, PU.1, Erg, Meis1, and Runx1 acting as upstream regulators in early hematopoietic cells","volume":"30","author":"Wilson","year":"2010","journal-title":"Mol Cell Biol."},{"key":"B37","doi-asserted-by":"publisher","first-page":"1103","DOI":"10.1210\/mend.11.8.9955","article-title":"Ascorbic acid-dependent activation of the osteocalcin promoter in MC3T3-E1 preosteoblasts: requirement for collagen matrix synthesis and the presence of an intact OSE2 sequence","volume":"11","author":"Xiao","year":"1997","journal-title":"Mol Endocrinol."},{"key":"B38","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1359\/jbmr.1999.14.6.893","article-title":"Isolation and characterization of MC3T3-E1 preosteoblast subclones with distinct in vitro and in vivo differentiation\/mineralization potential","volume":"14","author":"Wang","year":"1999","journal-title":"J Bone Miner Res."},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0070622","article-title":"Distinct mechanisms for induction and tolerance regulate the immediate early genes encoding interleukin 1beta and tumor necrosis factor alpha","author":"Adamik","year":"2013","journal-title":"PLoS ONE"},{"key":"B40","doi-asserted-by":"publisher","first-page":"3068","DOI":"10.2741\/2296","article-title":"Signaling and transcriptional regulation in osteoblast commitment and differentiation","volume":"12","author":"Huang","year":"2007","journal-title":"Front Biosci."},{"key":"B41","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1002\/biof.72","article-title":"Regulation of gene expression in osteoblasts","volume":"36","author":"Jensen","year":"2010","journal-title":"BioFactors"},{"key":"B42","doi-asserted-by":"publisher","first-page":"3044","DOI":"10.1093\/emboj\/18.11.3044","article-title":"The interaction of p62 with RIP links the atypical PKCs to NF-kappaB activation","volume":"18","author":"Sanz","year":"1999","journal-title":"EMBO J."},{"key":"B43","doi-asserted-by":"publisher","first-page":"36007","DOI":"10.1074\/jbc.C109.073627","article-title":"Sequestosome-1\/p62 is the key intracellular target of innate defense regulator peptide","volume":"284","author":"Yu","year":"2009","journal-title":"J Biol Chem."},{"key":"B44","doi-asserted-by":"publisher","first-page":"1607","DOI":"10.1002\/asia.200800099","article-title":"Improvement of photoaffinity SPR imaging platform and determination of the binding site of p62\/SQSTM1 to p38 MAP kinase","volume":"3","author":"Saito","year":"2008","journal-title":"Chem Asian J."},{"key":"B45","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1093\/jb\/mvn027","article-title":"Specific regulation of cytokine-dependent p38 MAP kinase activation by p62\/SQSTM1","volume":"143","author":"Kawai","year":"2008","journal-title":"J Biochem."},{"key":"B46","doi-asserted-by":"publisher","first-page":"7949","DOI":"10.1158\/0008-5472.CAN-10-1667","article-title":"Expression of the transcriptional repressor Gfi-1 is regulated by C\/EBP{alpha} and is involved in its proliferation and colony formation-inhibitory effects in p210BCR\/ABL-expressing cells","volume":"70","author":"Lidonnici","year":"2010","journal-title":"Cancer Res."},{"key":"B47","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1038\/ncb3276","article-title":"GFI1 proteins orchestrate the emergence of haematopoietic stem cells through recruitment of LSD1","volume":"18","author":"Thambyrajah","year":"2016","journal-title":"Nat Cell Biol."},{"key":"B48","doi-asserted-by":"publisher","first-page":"10338","DOI":"10.1128\/MCB.25.23.10338-10351.2005","article-title":"Gfi1 coordinates epigenetic repression of p21Cip\/WAF1 by recruitment of histone lysine methyltransferase G9a and histone deacetylase 1","volume":"25","author":"Duan","year":"2005","journal-title":"Mol Cell Biol."},{"key":"B49","first-page":":S331","article-title":"Lim-domain protein AJUBA is a required co-factor for Gfi1 suppression of Runx2 in pre-osteoblasts in multiple myeloma","volume":"30","author":"Adamik","year":"2015","journal-title":"J Bone Miner Res."},{"key":"B50","doi-asserted-by":"publisher","first-page":"32056","DOI":"10.1074\/jbc.M802320200","article-title":"Ajuba functions as a histone deacetylase-dependent co-repressor for autoregulation of the growth factor-independent-1 transcription factor","volume":"283","author":"Montoya-Durango","year":"2008","journal-title":"J Biol Chem."},{"key":"B51","doi-asserted-by":"publisher","first-page":"4010","DOI":"10.1128\/MCB.25.10.4010-4022.2005","article-title":"The LIM protein Ajuba influences interleukin-1-induced NF-kappaB activation by affecting the assembly and activity of the protein kinase Czeta\/p62\/TRAF6 signaling complex","volume":"25","author":"Feng","year":"2005","journal-title":"Mol Cell Biol."},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1186\/1546-0096-9-31","article-title":"The diagnosis and management of patients with idiopathic osteolysis","volume":"9","author":"Al Kaissi","year":"2011","journal-title":"Pediatr Rheumatol Online J."}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fendo.2018.00344\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,26]],"date-time":"2022-08-26T18:29:31Z","timestamp":1661538571000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fendo.2018.00344\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,6,29]]},"references-count":52,"alternative-id":["10.3389\/fendo.2018.00344"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2018.00344","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,6,29]]},"article-number":"344"}}